Literature DB >> 8358910

Pelvic reconstruction/total hip arthroplasty for metastatic acetabular insufficiency.

R H Walker1.   

Abstract

Four cases of pathologic periacetabular insufficiency/fracture in patients with extensive neoplastic metastatic involvement of the hemipelvis were treated by pelvic reconstruction with hemipelvis pin reinforcement with total hip arthroplasty (THA). Reconstruction was reserved for patients with limited other bony or visceral metastases, and had extreme narcotic-dependent pain and debilitation, or failed prior management, but had reasonable life/activity expectancy. Tumor palliation and hemipelvis reconstruction was obtained by ilioinguinal (pelvic) and posterolateral (hip) incisions. Iliac crest exposure allowed iliacus elevation, debulking of any intrapelvic soft-tissue mass, and exposure of the medial acetabulum. Rows of threaded Steinman pins were selectively passed from iliac crest (ilioinguinal incision) to superior and medial acetabular deficiencies (hip incision) in guided antegrade fashion. A reinforced polymethylmethacrylate (PMMA) acetabular reconstruction was then created, with PMMA incorporating medial and superior pins, an anti-protrusio ring, and a standard cemented acetabular component. A long-stem cemented femoral component was placed for proximal femoral metastasis prophylaxis. Postoperative rehabilitation (mean hospitalization, 12.7 days) was as for cemented THA. Mean survival was 15 months with integrity of the hip construct maintained throughout. All four patients progressed to independent ambulation with walking aids and were gratified that they had elected surgical treatment with reconstruction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358910

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  8 in total

1.  Surgical technique: Porous tantalum reconstruction for destructive nonprimary periacetabular tumors.

Authors:  Fazel A Khan; Peter S Rose; Michiro Yanagisawa; David G Lewallen; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2011-10-12       Impact factor: 4.176

2.  The survivorship of protrusio cages for metastatic disease involving the acetabulum.

Authors:  Mark Clayer
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

Review 3.  Reconstruction of multiple myeloma lesions around the pelvis and acetabulum.

Authors:  Vasileios I Sakellariou; Andreas F Mavrogenis; Olga Savvidou; Franklin H Sim; Panayiotis J Papagelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-10-19

4.  A long femoral stem is not always required in hip arthroplasty for patients with proximal femur metastases.

Authors:  Zhiqing Xing; Bryan S Moon; Robert L Satcher; Patrick P Lin; Valerae O Lewis
Journal:  Clin Orthop Relat Res       Date:  2013-01-30       Impact factor: 4.176

Review 5.  Reconstruction of the hip after resection of periacetabular oncological lesions: a systematic review.

Authors:  T S Brown; C G Salib; P S Rose; F H Sim; D G Lewallen; M P Abdel
Journal:  Bone Joint J       Date:  2018-01       Impact factor: 5.082

6.  Modified Harrington's procedure for periacetabular metastases in 89 cases: a reliable method for cancer patients with good functional outcome, especially with long expected survival.

Authors:  Gilber Kask; Jyrki Nieminen; Vincent van Iterson; Mihhail Naboistsikov; Toni-Karri Pakarinen; Minna K Laitinen
Journal:  Acta Orthop       Date:  2020-02-28       Impact factor: 3.717

7.  The Harrington plus reconstruction for pelvic and acetabular metastases.

Authors:  Mukai Chimutengwende-Gordon; Ross Coomber; Fidel Peat; Nadim Tarazi; Daud Chou; Andrew Carrothers
Journal:  J Bone Oncol       Date:  2022-02-03       Impact factor: 4.072

8.  Comparison of Porous Tantalum Acetabular Implants and Harrington Reconstruction for Metastatic Disease of the Acetabulum.

Authors:  Matthew T Houdek; Peter C Ferguson; Matthew P Abdel; Anthony M Griffin; Mario Hevesi; Kevin I Perry; Peter S Rose; Jay S Wunder; David G Lewallen
Journal:  J Bone Joint Surg Am       Date:  2020-07-15       Impact factor: 6.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.